The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index; none of the 14 sources its claims cite is checked for support yet.
The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold
Open accessAbstract
The fidelity and specificity of information flow within a cell is controlled by scaffolding proteins that assemble and link enzymes into signalling circuits. These circuits can be inhibited by bacterial effector proteins that post-translationally modify individual pathway components. However, there is emerging evidence that pathogens directly organize higher-order signalling networks through enzyme scaffolding, and the identity of the effectors and their mechanisms of action are poorly understood. Here we identify the enterohaemorrhagic Escherichia coli O157:H7 type III effector EspG as a regulator of endomembrane trafficking using a functional screen, and report ADP-ribosylation factor (ARF) GTPases and p21-activated kinases (PAKs) as its relevant host substrates. The 2.5 Å crystal structure of EspG in complex with ARF6 shows how EspG blocks GTPase-activating-protein-assisted GTP hydrolysis, revealing a potent mechanism of GTPase signalling inhibition at organelle membranes. In addition, the 2.8 Å crystal structure of EspG in complex with the autoinhibitory Iα3-helix of PAK2 defines a previously unknown catalytic site in EspG and provides an allosteric mechanism of kinase activation by a bacterial effector. Unexpectedly, ARF and PAKs are organized on adjacent surfaces of EspG, indicating its role as a ‘catalytic scaffold’ that effectively reprograms cellular events through the functional assembly of GTPase-kinase signalling complex.
Overview
CoChat Summary
TL;DR
The EHEC O157:H7 type III effector EspG acts as a catalytic scaffold that binds ARF GTPases and PAK kinases on adjacent surfaces, inhibiting ARF GTP hydrolysis while allosterically activating PAK2. Crystal structures of EspG–ARF6 and EspG–PAK2 Iα3 reveal how EspG reprograms membrane trafficking and kinase signalling.
Key findings
- EspG blocked hGH exocytosis, localized to the cis-Golgi, and induced Golgi fragmentation; microinjected 10 nM EspG disrupted Golgi and recycling endosome compartments without disrupting microtubules.
- A yeast two-hybrid screen yielded 26 positive interactions with ARF1, ARF6, PAK1, PAK2, and PAK3; EspG bound GTP-loaded ARF1/ARF6 but not GDP–ARF complexes.
- The 2.5 Å EspG–ARF6 structure showed EspG buries 602 Ų of ARF6 surface area and blocks ARF–GAP access, completely abolishing GAP-stimulated GTP hydrolysis on lipid-anchored ARF1; the binding-deficient EspG Glu392Arg mutant had no effect.
- The 2.8 Å EspG–PAK2 Iα3 structure showed EspG buries 684 Ų of PAK2 surface area and defines a catalytic site; EspG increased PAK2 activity (7.6 ± 2.5)-fold (n = 11), comparable to Cdc42 stimulation ((7.8 ± 3.4)-fold, n = 3), and a PAK2 probe localized to Golgi in 78 ± 5% of EspG-transfected cells.
Methods
- Functional screen: hGH secretion assay and eGFP-tagged effector localization in host cells; yeast two-hybrid screen for EspG interactors; in vitro binding with purified recombinant proteins.
- Structural analysis: crystallized EspG (residues 42–398) with ARF6 GTPase domain (residues 13–175) and with PAK2 Iα3-helix fragment; solved EspG–ARF6 at 2.5 Å by multiwavelength anomalous dispersion and EspG–PAK2 at 2.8 Å by molecular replacement.
- Cellular and biochemical assays: immunofluorescence, microinjection of 10 nM protein, kinase assays using immunoprecipitated pEGFP–PAK2 from 293T lysates with 10 µM ATP and 5 µCi γ32P[ATP], and Golgi-mimetic liposome reconstitution.
Limitations
- Stated limitations: Not stated in the paper.
- Evident from the text: structural conclusions use truncated constructs (EspG 42–398, ARF6 13–175, PAK2 Iα3 residues 121–136), so full-length protein context is not captured.
- Evident from the text: the new experiments are cell-based or in vitro; the paper cites prior in vivo infection studies but does not present an in vivo infection model here, and the VirA comparison is described as speculative.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 10 Not checked · 50 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, EspG interacted with ARF6GTP in its full-length myristoylated form, which was isolated from membrane fractions (Supplementary Fig. 4b).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“However, microtubules were intact in EspG microinjected cells (Fig. 1d), consistent with previous reports showing that these effectors do not disrupt cytoskeletal architectures14,15.”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
What the sources say
- Not checked yetcites [14] Germane, K. L., Ohi, R., Goldberg, M. B. & Spiller, B. W. Structural and functional studies indicate that Shigella VirA is not a protease and does not directly destabilize microtubules. Biochemistry 47, 10241–10243 (2008) source
- Not checked yetcites [15] Davis, J. et al. Novel fold of VirA, a type III secretion system effector protein from Shigella flexneri . Protein Sci. 17, 2167–2173 (2008) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, EspG disrupted the recycling endosome compartment in both transfection (Supplementary Fig. 1c, d) and microinjection experiments (data not shown).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Further structural analyses revealed that switch I is inaccessible to EspG when ARF6 adopts the GDP-bound conformation (Supplementary Fig. 4a).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The importance of conserved switch I residues for binding EspG were confirmed by mutational analysis on ARF6 (Supplementary Fig. 3c).”
§ The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
28 more claims
Create a free account to see all 60 claims and to verify the 14 references still open.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 2
- The quote only partly states this claim. 1
Citations
Cites
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,896
Minor, W., Cymborowski, M., Otwinowski, Z., & Chruszcz, M. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906019949 · Cited by 2,099
The Buccaneer software for automated model building. 1. Tracing protein chains
Cowtan, K. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906022116 · Cited by 1,822
Substructure solution with SHELXD
Schneider, T. R., & Sheldrick, G. M. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902011678 · Cited by 1,588
ARF proteins: roles in membrane traffic and beyond
D'Souza-Schorey, C., & Chavrier, P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1910 · Cited by 1,378
Biology of the p21-Activated Kinases
Bokoch, G. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161742 · Cited by 1,089
Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor
Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D., et al. (1998) · Science · doi:10.1126/science.280.5364.734 · Cited by 1,008
Cited by
Regulation of Small GTPases by GEFs, GAPs, and GDIs
Cherfils, J., & Zeghouf, M. (2013) · Physiological Reviews · doi:10.1152/physrev.00003.2012 · Cited by 1,245
ARF family G proteins and their regulators: roles in membrane transport, development and disease
Donaldson, J. G., & Jackson, C. L. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3117 · Cited by 934
Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels to mTORC1
Bar-Peled, L., Schweitzer, L. D., Zoncu, R., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.07.032 · Cited by 918
Scaffold Proteins: Hubs for Controlling the Flow of Cellular Information
Good, M. C., Zalatan, J. G., & Lim, W. A. (2011) · Science · doi:10.1126/science.1198701 · Cited by 885
Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements
Wong, A. R. C., Pearson, J. S., Bright, M. D., Munera, D., Robinson, K. S., Lee, S. F., Frankel, G., & Hartland, E. L. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07661.x · Cited by 377
Metadata
- Authors
- Selyunin, A. S., Sutton, S. E., Weigele, B. A., Reddick, L. E., Orchard, R. C., Bresson, S. M., Tomchick, D. R., & Alto, N. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Alto, Neal M.
- ORCID
- Venue
- Nature
- Published
- 2010-12-19
- Volume
- 469
- Issue
- 7328
- Pages
- 107-111
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3675890
- OpenAlex
- W2066507447
- Semantic Scholar
- a0ef535b6a6fc117794c76c088fad0e73e54f86a
- Cited by
- 120
- References
- 43
- Citations by year
- 2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 6 · 2014: 16 · 2013: 16 · 2012: 22
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Ariad Pharmaceuticals
- National Institute of Allergy and Infectious Diseases (R01AI083359, T32AI007520)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Escherichia coli O157:H7, type III effectors, bacterial effector proteins, ARF6, p21-activated kinase, PAK2, GTPase-activating protein, endomembrane trafficking, vesicle budding, crystal structure, enterohemorrhagic Escherichia coli, host-pathogen interaction
- MeSH terms
- Allosteric Regulation, Animals, Biological Transport, Cell Line, Endoplasmic Reticulum, Enzyme Activation, Golgi Apparatus, Guanosine Triphosphate, Humans, Hydrolysis, Intracellular Membranes, Models, Molecular, Protein Binding, Protein Conformation, Signal Transduction, Crystallography, X-Ray, Escherichia coli O157, Catalytic Domain, ADP-Ribosylation Factors, Two-Hybrid System Techniques, Protein Interaction Mapping, Escherichia coli Proteins, Mice, Rats, p21-Activated Kinases, Biocatalysis, Protein Unfolding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold. https://app.cochat.ai/papers/10.1038/nature09593
- The paper
- Selyunin, A. S., Sutton, S. E., Weigele, B. A., Reddick, L. E., Orchard, R. C., Bresson, S. M., Tomchick, D. R., & Alto, N. M. (2011). The assembly of a GTPase–kinase signalling complex by a bacterial catalytic scaffold. Nature. https://doi.org/10.1038/nature09593
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.